rs116272561
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_015340.4(LARS2):c.765G>A(p.Ala255Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000831 in 1,609,118 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_015340.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00430 AC: 654AN: 152166Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00104 AC: 259AN: 250096Hom.: 0 AF XY: 0.000740 AC XY: 100AN XY: 135052
GnomAD4 exome AF: 0.000468 AC: 682AN: 1456834Hom.: 9 Cov.: 30 AF XY: 0.000375 AC XY: 272AN XY: 724386
GnomAD4 genome AF: 0.00430 AC: 655AN: 152284Hom.: 4 Cov.: 32 AF XY: 0.00396 AC XY: 295AN XY: 74464
ClinVar
Submissions by phenotype
not provided Benign:4
- -
- -
- -
- -
not specified Benign:1
Ala255Ala in exon 9 of LARS2: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 1.5% (67/4406) of Af rican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs116272561). -
LARS2-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at